<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01640886</url>
  </required_header>
  <id_info>
    <org_study_id>MP2012-A</org_study_id>
    <nct_id>NCT01640886</nct_id>
  </id_info>
  <brief_title>Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA</brief_title>
  <official_title>Prospective Study Into the Performance of the KeyPathtm MRSA/MSSA Blood Culture Test - BTA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MicroPhage, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MicroPhage, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In vitro identification of S. aureus,methicillin-sensitive S. aureus (MSSA) and
      methicillin-resistant S. aureus (MRSA)from positive blood culture using MicroPhage's
      bacteriophage-based diagnostic platform.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center clinical study to investigate the effectiveness of the performance of
      the KeyPath MRSA/MSSA Blood Culture Test - BTA. The KeyPath test is performed directly on
      positive blood culture specimens from bioMerieux BacT/ALERT blood culture bottles. The
      MicroPhage test will be compared to standards and market available tests with similar
      indications (comparators). It is estimated that the study will last 3-4 months depending on
      the accural rate at the institutions.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Results did not meet study requirements.
  </why_stopped>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prospective study into the performance of the KeyPath MRSA/MSSA Blood Culture Test -BTA</measure>
    <time_frame>3-4 months</time_frame>
    <description>A. Determination of the performance of the KeyPathTM MRSA/MSSA Blood Culture Test - BTA for identification of S. aureus and determination of MRSA and MSSA direct from clinical blood culture positives by:
i. KeyPathTM MRSA/MSSA Blood Culture Test - BTA for identification of S. aureus to the reference methods for S. aureus (tube coagulase and Staphaurex).
ii. KeyPathTM MRSA/MSSA Blood Culture Test - BTA for determination of MRSA and MSSA among S. aureus positives by comparison to the reference method (30 µg cefoxitin disc diffusion).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">764</enrollment>
  <condition>Bacteremia</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <description>Comparison of S. aureus to the reference methods for S. aureus (tube coagulase and Staphaurex.)
Comparison to the reference method (30 ug cefoxitin disc diffusion).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KeyPath Test Group</arm_group_label>
    <description>All specimens collected that meet the inclusion criteria will be tested using the KeyPath BTA Test.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Retention of de-identified blood culture specimens only.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hospital patients with Gram positive blood cultures determined to be positive with the
        following bottle types:

          1. bioMerieux BacT/Alert Standard Aerobic and Anaerobic

          2. bioMerieux BacT/Alert FAN Aerobic and FAN Anaerobic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Blood culture samples determined to be Gram-positive from subjects aged 18+,
             inclusive, with any of the following bottle types:

               -  bioMerieux BacT/ALERT® Standard Aerobic and Anaerobic

               -  bioMerieux BacT/ALERT® FAN Aerobic and FAN Anaerobic

          2. Completion of the KeyPathTM BTA Test on the sample.

          3. Completion of the reference method for S. aureus identification (tube coagulase and
             Remel Staphaurex ) and completion of the reference method for methicillin resistance
             determination (30 µg cefoxitin disc diffusion) for S. aureus positive samples.

        Exclusion Criteria:

          1. Samples from blood culture positives over 24 hours from alarm

          2. Samples deemed contaminated.

          3. Violations and/or deviations from the KeyPathTM BTA Test protocol and/or other
             included test protocols under study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dipankar Manna, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MicroPhage, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arizona, Infectious Disease Research</name>
      <address>
        <city>Tuscon</city>
        <state>Arizona</state>
        <zip>85721</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCLA Clinical Laboratory</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90049</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2012</study_first_submitted>
  <study_first_submitted_qc>July 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2012</study_first_posted>
  <last_update_submitted>January 14, 2013</last_update_submitted>
  <last_update_submitted_qc>January 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Staphylococcus aureus</keyword>
  <keyword>methicillin resistant</keyword>
  <keyword>MRSA</keyword>
  <keyword>MSSA</keyword>
  <keyword>Blood Culture</keyword>
  <keyword>Diagnostic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

